Brian Lian, President & CEO at Viking Therapeutics, Inc. (VKTX), sold 369,980 shares at $43.32 ($15.8M) on 2025-01-06, disclosed to the SEC on 2025-01-06.
Seasonal sale ($15.8M) by President & CEO — this insider has traded VKTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.68 | 175,490 | $7.5M | 47.4% |
| 2 | $42.68 | 175,490 | $7.5M | 47.4% |
| 3 | $43.32 | 19,000 | $823K | 5.2% |
| Total | $42.71 avg | 369,980 | $15.8M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $2.7M | — | Filing → |
| VKTX | SELL | 2025-07-03 | $1.5M | — | Filing → |
| VKTX | SELL | 2024-09-20 | $30.6M | — | Filing → |